Triamcinolone Acetonide NDC 61919-650

NDC codes

FDA NDC Directory

Product NDC (as listed)61919-650Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61919-0650Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
61919-650-15	61919065015	15 g in 1 TUBE (61919-650-15)Marketed from Mar 5, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Triamcinolone Acetonide
Generic name (nonproprietary): triamcinolone acetonide
Active ingredients: Triamcinolone acetonide — 1 mg/g
Dosage form: Cream
Route: Topical
Labeler: DIRECTRX
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 085692
Marketing start: Mar 5, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 61919-650_4d3a81d3-8f47-ac04-e063-6394a90a545dSPL ID 4d3a81d3-8f47-ac04-e063-6394a90a545dSPL set ID 835bbcd1-3869-646c-e053-2a91aa0a796aRxCUI 1014314, 1085636UNII F446C597KA
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461919065015 followed by a unit qualifier and the quantity

Package 61919-0650-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 17, 2026.

Indications (excerpt from the label)

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 085692

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 085692
Product	Strength	Form · route	Labeler	Product NDC
Triamcinolone Acetonide	Triamcinolone acetonide .25 mg/g	CreamTopical	Proficient Rx LP	63187-214
triamcinolone acetonide	Triamcinolone acetonide .25 mg/g	CreamTopical	E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC	0168-0003
triamcinolone acetonide	Triamcinolone acetonide 1 mg/g	CreamTopical	E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC	0168-0004
triamcinolone acetonide	Triamcinolone acetonide .25 mg/g	CreamTopical	Preferred Pharmaceuticals Inc.	68788-8515
triamcinolone acetonide	Triamcinolone acetonide 5 mg/g	CreamTopical	Preferred Pharmaceuticals Inc.	68788-8892
Triamcinolone Acetonide	Triamcinolone acetonide 1 mg/g	CreamTopical	Proficient Rx LP	63187-053
triamcinolone acetonide	Triamcinolone acetonide .25 mg/g	CreamTopical	A-S Medication Solutions	50090-0293
triamcinolone acetonide	Triamcinolone acetonide 5 mg/g	CreamTopical	E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC	0168-0002